Listen to this page using ReadSpeaker

Delaware News



 Pages Tagged With: "Fraud Division"

Moody’s Agrees to Settlement With States and Federal Government Over Securities Ratings

States, USDOJ Alleged Moody’s Inflated Ratings and Contributed To Market Crash. Attorney General Matt Denn joined the U.S. Department of Justice and 20 other attorneys general in announcing a settlement resolving an investigation into Moody’s Corporation, Moody’s Investors Service, Inc., and Moody’s Analytics, Inc. (collectively “Moody’s”) over the companies’ misrepresentations regarding the independence and objectivity […]




Maker of Opioid Addiction Treatment Drug Suboxone Accused of Conspiring to Keep Monopoly Profits

Delaware Attorney General Matt Denn and other attorneys general yesterday filed an antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices. Reckitt Benckiser Pharmaceuticals, now known as Indivior, […]







 Pages Tagged With: "Fraud Division"

Moody’s Agrees to Settlement With States and Federal Government Over Securities Ratings

States, USDOJ Alleged Moody’s Inflated Ratings and Contributed To Market Crash. Attorney General Matt Denn joined the U.S. Department of Justice and 20 other attorneys general in announcing a settlement resolving an investigation into Moody’s Corporation, Moody’s Investors Service, Inc., and Moody’s Analytics, Inc. (collectively “Moody’s”) over the companies’ misrepresentations regarding the independence and objectivity […]




Maker of Opioid Addiction Treatment Drug Suboxone Accused of Conspiring to Keep Monopoly Profits

Delaware Attorney General Matt Denn and other attorneys general yesterday filed an antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices. Reckitt Benckiser Pharmaceuticals, now known as Indivior, […]